Steven C Schumann

Title: Innovations of Steven C Schumann

Introduction

Steven C Schumann is an accomplished inventor based in Elgin, IL (US). He holds a total of 3 patents that showcase his contributions to the field of pharmaceuticals. His work primarily focuses on modified-release formulations, which have significant implications for the treatment of microbial infections.

Latest Patents

Among his latest patents are innovative pharmaceutical compositions that provide a modified release profile for once-daily dosing of metronidazole. These compositions are designed to exhibit substantial bioequivalence to immediate-release metronidazole administered three times a day. The formulations include a specific percentage of metronidazole, along with various excipients that enhance the drug's release characteristics and stability.

Career Highlights

Throughout his career, Steven has worked with notable companies, including G.D. Searle & Company. His expertise in pharmaceutical sciences has led to the development of effective treatment options that improve patient compliance and therapeutic outcomes.

Collaborations

Steven has collaborated with esteemed colleagues such as Subhash Desai and Alan Mark Mancini. Their combined efforts have contributed to advancements in pharmaceutical formulations and drug delivery systems.

Conclusion

Steven C Schumann's innovative work in modified-release pharmaceutical compositions highlights his significant contributions to the field. His patents reflect a commitment to improving treatment methodologies and enhancing patient care.